Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.

The IPROACTIF intervention is based on the premise of preventing the physical and cognitive decline that is associated with aging and chronic disease. The 12-week intervention includes a comprehensive assessment of ADL functioning and ten intervention sessions addressing disease management, physical activity and executive functioning. This pilot randomized control trial will compare whether patients who receive IPROACTIF perform better than usual care patients on physical functioning, self-efficacy for chronic disease management, physical activity levels, executive functioning, health-related quality of life, and participation in life roles and activities.

Inclusion Criteria:

• English speaking
• Community-dwelling
• 55 years of age
• Primary diagnosis of heart disease (coronary artery disease, ischemic heart disease, hypertensive heart disease), or uncontrolled diabetes (HBA1c greater than/equal to 10)
• Self-reported risk of functional decline (score of 3 or higher) on the 11-item Brief Risk Identification of Geriatric Health Tool or self-reported need for assistance with disease management

Exclusion Criteria

• Current/past diagnosis of stroke or other neurological disorders
• Receiving pharmacological treatment for cognition
• Participating in other exercise or ADL-focused intervention studies
• Non-English speaking
• Residing in a long-term care institution
• Compromised decision-making capacity (score >8 on SOMCT)